Bayer's Mirena Gets FDA Approval for Extended Use as Contraceptive

By Cristina Roca

Bayer AG said Thursday that the U.S. Food and Drug Administration has approved its Mirena device for extended use as a contraceptive.

The German pharmaceutical and chemicals company said its supplemental new drug application for use of up to eight years in the contraception indication was approved by the regulator.

Mirena is a hormonal intrauterine system.

Its duration of use remains unchanged at up to five years for its second approved indication in the U.S.

Write to Cristina Roca at [e-mail]

(END) Dow Jones Newswires

08-18-22 0903ET